Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
about
Early invasive versus conservative strategy for non-infarct related artery lesions in ST elevation myocardial infarction with multi-vessel diseaseA Review of the Key Clinical Trials of 2015: Results and ImplicationsMultivessel Revascularization Does Not Increase Contrast-Induced Acute Kidney Injury Incidence in Acute Myocardial Infarction: A Meta-Analysis.Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.Does the evidence really suggest that we should completely revascularise bystander disease in patients with ST elevation myocardial infarction undergoing primary angioplasty? Why we still need more definitive trial data to change routine practice.Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.Double jeopardy in acute ST-segment elevation myocardial infarctionThe successful use of autologous skin in management of guidewire-induced distal coronary perforation.Fractional flow reserve: a clinical perspective.Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study.Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.The Systematic Evaluation of Identifying the Infarct Related Artery Utilizing Cardiac Magnetic Resonance in Patients Presenting with ST-Elevation Myocardial Infarction.Staged versus One-Time Complete Revascularization with Percutaneous Coronary Intervention in STEMI Patients with Multivessel Disease: A Systematic Review and Meta-Analysis.Fractional flow reserve in 2017: current data and everyday practice.Comparison of Approaches to Revascularization in Patients With Multivessel Coronary Artery Disease Presenting With ST-Segment Elevation Myocardial Infarction: Meta-analyses of Randomized Control Trials.Staged versus "one-time" multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome.Completeness of revascularization in multivessel coronary artery disease.Complete Revascularization of Simultaneous Multiple Culprit Lesions in a Septuagenarian with ST-Elevation Myocardial Infarction.Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: an observational study.Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.Culprit lesion-only versus complete revascularization in patients with STEMI: Lessons learned from PRAMI, CvLPRIT, and DANAMI-3 PRIMULTI.Evaluation of intermediate coronary stenoses in acute coronary syndromes using pressure guidewire.Reperfusion strategies in acute myocardial infarction and multivessel disease.The year in cardiology 2015: acute coronary syndromes.Almanac 2015: coronary artery disease.Percutaneous Coronary Intervention: 2015 in Review.Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease.Fractional flow reserve to guide surgical coronary revascularization.Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.Current and novel approaches to treat patients presenting with ST elevation myocardial infarction.Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.Determinants of excess mortality following unprotected left main stem percutaneous coronary intervention.Infarct related artery only versus complete revascularization in ST-segment elevation myocardial infarction and multi vessel disease: a meta-analysis.Clinical values of left ventricular mechanical dyssynchrony assessment by gated myocardial perfusion SPECT in patients with acute myocardial infarction and multivessel disease.Staged re-evaluation of non-culprit lesions in ST segment elevation myocardial infarction: a retrospective study[Immediate multivessel PCI in patients with ACS : Is less more?]Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease.
P2860
Q24187435-50F65E80-04E1-4B0E-BB4B-B3C180713502Q28077170-7422BEE2-8292-48A8-A2B1-B40EE4355DCFQ30248222-01841163-E5FA-4680-AFB0-6158BFEF7758Q31110506-EF2B2B12-88F7-4AB3-B24F-135C84B2CAB5Q31149523-4EF27494-B78D-481F-9910-FDE70AE9F6B7Q31155926-C517F7A4-3BCB-4FCD-A57F-8B638A3A3934Q33567743-926DEC60-739E-4641-92D8-F2BC56371D9FQ33761053-5EC2EBD7-82F4-4F36-B5BE-D444DF8B80B5Q33849439-927E1659-E7EA-4029-9058-399880B3B24FQ36156568-F8092B61-8FE4-4729-94D2-E1D84354DA5CQ36227047-7FD92A46-D29C-4B8B-95EA-E297C0274C12Q36242616-4A4A04E0-EAF0-4536-816A-E65378D884FBQ36255696-9A8744E5-C8A9-4257-8F93-3730AFC5FE63Q36364120-12A5AF8D-D3ED-4E04-BFB3-08E8B53356D7Q36836353-E9665FBC-E118-4952-938A-6DC89FD3D120Q37437857-A3485B9A-E385-4B04-AF48-F1AC60C869CDQ37528229-F0001803-A15A-4320-A2F4-269297C772C5Q37567965-7D28011A-FB62-430E-BA73-C48D677B89E5Q37600083-8162EF65-C814-49C4-A4A0-5F40721FBD3CQ37741700-9B12E0B6-1BF8-44C9-B8BA-719D37326637Q38380111-C42F55E4-16F0-4C72-B5B1-CC2355C0AE0DQ38472363-63861DF4-3796-4850-9A71-4749C4EE5D3FQ38650389-6286C6DA-5D84-4A02-B3AE-B0E21B70CFD5Q38665263-F9F5B0B3-AE77-483B-A0BA-AE6D1F591AF7Q38685680-2245A6C5-F98B-4BBE-8F8C-2A900914CEAEQ38714574-9F9B1CE8-46D1-4952-8703-B1422D66AAFDQ38728869-33996690-2252-4341-ACA0-A03BF477ED16Q38762240-7F18169F-F15F-4682-AEA4-250CFAC95434Q38764034-B4765C01-35D2-4F26-A58F-B97D9D906D90Q38766238-5F4EA968-54C1-4B16-A6AE-C7F48C849B20Q38805546-F5AA6B69-8E3B-4153-A3D2-F99230C894A6Q38855389-797B2412-0AEC-4F56-AF17-2D369F98DB10Q38875527-A1C460F0-9DB4-4872-90E5-677F8A0D6A8AQ38884187-42BF9869-1523-4134-B8DA-7F6D58877B83Q38977729-E4451899-2443-41AD-80FB-BBEB047E91CDQ39279308-16CBF20E-3C66-4EE9-95EE-D1D7C7411087Q39610970-7C08CFCB-B32D-4A02-9672-228CFACBAD11Q40525633-C7080ADD-0AA4-493A-90F7-F21C685F8DB0Q40534404-F912A35A-227B-4762-8ADC-66F24B483832Q40726736-B535F5AA-09F5-4DBD-BFE7-6B509A037D22
P2860
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Complete revascularisation ver ...... , randomised controlled trial.
@en
type
label
Complete revascularisation ver ...... , randomised controlled trial.
@en
prefLabel
Complete revascularisation ver ...... , randomised controlled trial.
@en
P2093
P1433
P1476
Complete revascularisation ver ...... , randomised controlled trial.
@en
P2093
Anton Boel Villadsen
Bent Raungaard
DANAMI-3—PRIMULTI Investigators
Dan Eik Høfsten
Erik Jørgensen
Frants Pedersen
Hans-Henrik Tilsted
Henning Kelbæk
Jan Ravkilde
Jens Aarøe
P304
P356
10.1016/S0140-6736(15)60648-1
P407
P50
P577
2015-08-01T00:00:00Z